Galanthamine hydrobromide

CAS : 1953-04-4

Ref. 3D-FH15701

Informations sur le produit

• Nom: Galanthamine hydrobromide
• Synonymes: 4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromideGalantamine hydrobromide, (4aS,6R,8aS)-6-hydroxy-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium, 5A,6,7,8,8A,12B-Hexahydrogalanthamine Hydrobromide (1:1), 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aS,6R,8aS)-, 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aS,6R,8aS)-, Galantamine Hbr, Galantamine Hydrobromide, Galanthamine HBr, Galanthamine Hydrobromide (1:1), Galanthamine hydrogen bromide, Jilkon hydrobromide, Lycoremine hydrobromide, Nivalin, Nivaline, Nivaline (pharmaceutical), Razadyne, Reminyl, Tamilin

Description

A reversible and competitive inhibitor of acetylcholinesterase (AChE) that is approved for the treatment of Alzheimer’s disease. It is also an allosteric modulator of nicotinic acetylcholine receptors (nAChR). Activation of nAChR along with upregulation of anti-apoptotic protein Bcl-2 prevents apoptosis and therefore provides neuroprotection.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 368.27 g/mol
• Formule: C₁₇H₂₁NO₃·HBr
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder